Growth Metrics

InspireMD (NSPR) Cash from Financing Activities (2016 - 2025)

InspireMD filings provide 15 years of Cash from Financing Activities readings, the most recent being $52.9 million for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities rose 5584.56% to $52.9 million in Q3 2025 year-over-year; TTM through Dec 2025 was $55.6 million, a 9192.47% increase, with the full-year FY2025 number at $55.6 million, up 201.15% from a year prior.
  • Cash from Financing Activities hit $52.9 million in Q3 2025 for InspireMD, up from $2.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $52.9 million in Q3 2025 to a low of -$965000.0 in Q3 2024.
  • Median Cash from Financing Activities over the past 4 years was $506000.0 (2025), compared with a mean of $10.1 million.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 1168833.33% in 2021 and later tumbled 194.29% in 2022.
  • InspireMD's Cash from Financing Activities stood at -$35000.0 in 2021, then tumbled by 194.29% to -$103000.0 in 2022, then soared by 1617.48% to $1.6 million in 2024, then soared by 3286.18% to $52.9 million in 2025.
  • The last three reported values for Cash from Financing Activities were $52.9 million (Q3 2025), $2.1 million (Q2 2025), and $506000.0 (Q1 2025) per Business Quant data.